Purchases and Sales Made in Q1 2024 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q1 2024. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-986- 77.45% |
$17.4K - $29.2K
|
287
$769
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-1K- 8.2% |
$17.8K - $29.7K
|
11.2K
$30.1K
|
|
|
Apr 23, 2024
Q1 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-1.09K- 75.77% |
$19.2K - $32.1K
|
347
$930
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.4K- 23.37% |
$24.8K - $41.4K
|
4.59K
$12.3K
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-1.84K- 14.05% |
$32.6K - $54.5K
|
11.3K
$30.2K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.89K- 38.59% |
$51K - $85.3K
|
4.59K
$12.3K
|
|
|
May 14, 2024
Q1 2024
|
Entry Point Capital, LLC
New York, NY |
SELL
|
- |
-3.01K- 49.03% |
$53.2K - $88.9K
|
3.13K
$8.38K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-3.19K- 91.74% |
$56.4K - $94.3K
|
287
$769
|
|
|
May 13, 2024
Q1 2024
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-6.55K- 12.87% |
$116K - $194K
|
44.3K
$119K
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-7.52K- 48.86% |
$133K - $222K
|
7.87K
$21.1K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-8.77K- 25.02% |
$155K - $259K
|
26.3K
$70.4K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-8.77K- 25.02% |
$155K - $259K
|
26.3K
$70.4K
|
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-8.89K- 24.33% |
$157K - $263K
|
27.7K
$74.1K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-13.8K- 60.71% |
$244K - $408K
|
8.92K
$23.9K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-17.7K- 2.43% |
$313K - $523K
|
710K
$1.9M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-25.5K- 49.23% |
$451K - $754K
|
26.3K
$70.4K
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-41.7K- 9.43% |
$736K - $1.23M
|
400K
$1.07M
|
|
|
May 15, 2024
Q1 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-142K- 11.71% |
$2.51M - $4.2M
|
1.07M
$2.87M
|
|
|
May 15, 2024
Q1 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-150K- 14.46% |
$2.65M - $4.44M
|
888K
$2.38M
|
|
|
May 15, 2024
Q1 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-192K- 25.31% |
$3.39M - $5.66M
|
565K
$1.52M
|
|
|
May 15, 2024
Q1 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-263K- 24.87% |
$4.65M - $7.78M
|
795K
$2.13M
|